Data have also been accepted for publication as an original article by the peer-reviewed Journal of Electrocardiology
SANTA CLARA, Calif., March 4 /PRNewswire-FirstCall/ -- NewCardio, Inc. (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that Dr. Ihor Gussak, NewCardio's Vice President and Chief Medical Officer, will present at the American College of Cardiology (ACC) 58th Annual Scientific Session in Orlando on March 29, 2009.
Dr. Gussak, on behalf of Drs. Branislav Vajdic (NewCardio's Chief Executive Officer), Samuel George (Senior Consultant to NewCardio), Ljupco Hadzievski, Steven F. Francom, and Peter Kowey (a member of NewCardio's Scientific Advisory Board), will present "Comparison of QTinno, a Fully Automated ECG Analysis Program, to Semi-Automated Methods in Analysis of ECGs From a Drug Safety Study." Also, a full-size, original article on QTinno performance has been accepted for publication by The Journal of Electrocardiology.
The conference features the latest and most innovative findings in cardiovascular science, as well as the most clinically relevant practical applications. More information on this conference is available at http://acc09.acc.org/Pages/default.aspx online.
Dr. Gussak commented, "The presented data demonstrates outstanding accuracy, reproducibility, and consistency of our 3-dimensional platform technology in the key electrocardiographic interval measurements, which enables the fully automated reading of ECGs in drug safety and Thorough QT studies. Unlike manual, semi-automated, and other 2-dimensional technologies and approaches, NewCardio's proprietary 3-dimensional platform technology not only matches the most rigorous manual readings from some of the world's most highly trained cardiologists in a fully automated manner, but also demonstrates very lo
|SOURCE NewCardio, Inc.|
Copyright©2009 PR Newswire.
All rights reserved